LifeVantage Corp Files Current Report

Ticker: LFVN · Form: 8-K · Filed: Apr 16, 2024 · CIK: 849146

Lifevantage Corp 8-K Filing Summary
FieldDetail
CompanyLifevantage Corp (LFVN)
Form Type8-K
Filed DateApr 16, 2024
Risk Levellow
Pages4
Reading Time4 min
Key Dollar Amounts$0.0001, $5,000,000
Sentimentneutral

Sentiment: neutral

Topics: corporate-filing, 8-K

Related Tickers: LFVN

TL;DR

LFVN filed an 8-K on 4/12, updating corporate info & Nasdaq listing.

AI Summary

LifeVantage Corporation filed an 8-K on April 12, 2024, reporting its current activities. The filing indicates the company's principal executive offices are located at 3300 Triumph Blvd, Suite 700, Lehi, Utah 84043. LifeVantage Corporation's common stock is registered on The Nasdaq Stock Market LLC under the trading symbol LFVN.

Why It Matters

This 8-K filing serves as a notification of current events for LifeVantage Corporation, providing essential corporate information and stock exchange details.

Risk Assessment

Risk Level: low — This filing is a routine corporate disclosure and does not contain information that inherently increases risk.

Key Players & Entities

  • LifeVantage Corporation (company) — Registrant
  • April 12, 2024 (date) — Date of earliest event reported
  • 3300 Triumph Blvd , Suite 700 (address) — Principal executive offices
  • Lehi , Utah 84043 (address) — Principal executive offices
  • LFVN (ticker) — Trading Symbol
  • The Nasdaq Stock Market LLC (company) — Exchange

FAQ

What is the primary purpose of this Form 8-K filing for LifeVantage Corporation?

The primary purpose is to report current information about the company as required by the Securities Exchange Act of 1934.

When was the earliest event reported in this filing?

The earliest event reported was on April 12, 2024.

Where are LifeVantage Corporation's principal executive offices located?

The principal executive offices are located at 3300 Triumph Blvd, Suite 700, Lehi, Utah 84043.

On which stock exchange is LifeVantage Corporation's common stock registered?

LifeVantage Corporation's common stock is registered on The Nasdaq Stock Market LLC.

What is the trading symbol for LifeVantage Corporation's common stock?

The trading symbol for LifeVantage Corporation's common stock is LFVN.

Filing Stats: 1,120 words · 4 min read · ~4 pages · Grade level 12.3 · Accepted 2024-04-16 16:07:24

Key Financial Figures

  • $0.0001 — ) of the Act: Common Stock, par value $0.0001 LFVN The Nasdaq Stock Market LLC Title
  • $5,000,000 — ggregate principal amount not to exceed $5,000,000 (the "Line of Credit"). In the event t

Filing Documents

01

Item 1.01. Entry into a Material Definitive Agreement. On April 12, 2024, LifeVantage Corporation (the "Company") entered into a Loan Agreement (the "Loan Agreement") with Bank of America, N.A., as Lender (the "Lender"). In connection with the Loan Agreement and on the same date, the Company, Lifeline Nutraceuticals Corporation, as Guarantor (the "Guarantor"), and the Lender also entered into a Continuing and Unconditional Guaranty (the "Continuing and Unconditional Guaranty") and a Security and Pledge Agreement (the "Security and Pledge Agreement"). The Loan Agreement provides for a revolving line of credit in aggregate principal amount not to exceed $5,000,000 (the "Line of Credit"). In the event the Company borrows under the Line of Credit, interest will be payable commencing May 31, 2024, and then on the last day of each month thereafter until payment in full of all principal outstanding under the Line of Credit, with all unpaid principal and interest due on April 12, 2027 (the "Expiration Date"). The Line of Credit will bear interest at a rate per year equal to the sum of (i) the greater of the Term SOFR Daily Floating Rate (as defined in the Loan Agreement) or 0.00%, plus (ii) 2.00%. Amounts under the Line of Credit may be repaid and re-borrowed from time to time until the Expiration Date. The Company's obligations under the Loan Agreement are secured by a security interest in substantially all of the assets of the Company and the Guarantor, as further provided for in the Security and Pledge Agreement. Pursuant to the Continuing and Unconditional Guaranty, the Guarantor guarantees and promises to pay promptly to the Lender all indebtedness of the Company when due. The Loan Agreement contains customary covenants, including affirmative and negative covenants that in certain circumstances restrict the Company's ability to incur additional indebtedness, make certain investments, purchase or otherwise acquire all or substantially all the assets or equity inte

03

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. To the extent required by Item 2.03 of Form 8-K, the information regarding the Loan Agreement, the Continuing and Unconditional Guaranty, and the Security and Pledge Agreement set forth under Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 2.03.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Loan Agreement, dated as of April 12, 2024, between LifeVantage Corporation and Bank of America, N.A. 10.2 Continuing and Unconditional Guaranty, dated as of April 12, 2024, among LifeVantage Corporation, as Borrower, Lifeline Nutraceuticals Corporation, as Guarantor, and Bank of America, N.A. 10.3 Security and Pledge Agreement, dated as of April 12, 2024, among LifeVantage Corporation, as Borrower, Lifeline Nutraceuticals Corporation, as Guarantor, and Bank of America, N.A. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: April 16, 2024 By: LIFEVANTAGE CORPORATION /s/ Steven R. Fife Name: Steven R. Fife Title: President and Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.